Literature DB >> 4400558

A clinical trial of folic acid in Parkinson's disease.

P L McGeer, L Zeldowicz, E G McGeer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4400558      PMCID: PMC1940357     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Toxicity of folic acid given in pharmacological doses to healthy volunteers.

Authors:  R Hunter; J Barnes; H F Oakeley; D M Matthews
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

2.  Urinary metabolites in Parkinson's disease.

Authors:  F A Kuehl; W J Vandenheuvel; R E Ormond
Journal:  Nature       Date:  1968-01-13       Impact factor: 49.962

3.  On the role of pteridines as cofactors for tyrosine hydroxylase.

Authors:  L Ellenbogen; R J Taylor; G B Brundage
Journal:  Biochem Biophys Res Commun       Date:  1965-06-09       Impact factor: 3.575

4.  Cholinergic enzyme systems in Parkinson's disease.

Authors:  P L McGeer; E G McGeer
Journal:  Arch Neurol       Date:  1971-09

5.  Distribution of tyrosine hydroxylase in human and animal brain.

Authors:  E G McGeer; P L McGeer; J A Wada
Journal:  J Neurochem       Date:  1971-09       Impact factor: 5.372

6.  Tyrosine hydroxylase.

Authors:  S Udenfriend
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Some characteristics of brain tyrosine hydroxylase.

Authors:  E G McGeer; S Gibson; P L McGeer
Journal:  Can J Biochem       Date:  1967-10

8.  Aseptic addition method for Lactobacillus casei assay of folate activity in human serum.

Authors:  V Herbert
Journal:  J Clin Pathol       Date:  1966-01       Impact factor: 3.411

  8 in total
  1 in total

1.  Initiation of treatment in early PD (evidences based).

Authors: 
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.